Year: 2025 | Month: October-December | Volume: 10 | Issue: 4 | Pages: 88-96
DOI: https://doi.org/10.52403/gijhsr.20250410
Transforming Medicine Through 3D Printing: Evaluating Its Impact on Devices, Drugs and Organ Bioprinting
Kairaa Sri Mehta
Student at The Sheffield Private School, Sharjah, UAE
ABSTRACT
This paper examines the transformative potential of 3D printing in the medical field, focusing on its applications in medical devices, pharmaceuticals and organ bioprinting. It evaluates how additive manufacturing enables the creation of cost-effective, patient-specific devices such as prosthetics, implants and hearing aids, which are already in mainstream use. In pharmaceuticals, 3D printing has facilitated the production of personalised drugs, exemplified by the FDA-approved Spritam, though scalability and regulatory challenges hinder wider adoption. The paper also explores advancements in organ bioprinting, where printed tissues and miniature organs indicate future solutions to organ shortages. While 3D printing is reshaping aspects of healthcare, its adoption remains uneven due to ethical, technical and financial barriers. Ultimately, overcoming these challenges could allow 3D printing to revolutionise medicine by delivering safer, more personalised and accessible healthcare solutions worldwide.
Keywords: 3D printing, medical devices, personalised medicine, organ bioprinting, healthcare innovation